All episodes

In this December special episode, your UEG Journal podcast hosts H. Tarik Kani and Ahsen Ustaoglu are joined by UEG Talks podcast hosts Egle Dieninyte and Pradeep Mundre in hosting very special guests at UEG Week 2023 in Copenhagen. You can expect to hear important insights from Dr Enrique de Madaria and UEG Journal Editor-in-Chief Prof Joost Drenth, as well as Young GIs.

Dr. H. Tarik Kani talks to Dr. Anouk Wijnands (Netherlands) about her multicenter cohort study that investigated the relationship between smoking and colorectal neoplasia in patients with Inflammatory Bowel Disease with a 10-year follow-up.

Dr Ahsen Ustaoglu interviews Dr Iris Levink on her study investigating the additive value of CA19.9 monitoring in a pancreatic cyst surveillance program, part of the PACYFIC-trial (www.pacyfic.net).

Dr. H. Tarik Kani talks to Dr. Axel Dignass (Germany) about his recent publication about the impact of Ustekinumab on health-related quality of life in moderate-to-severe Crohn’s disease which was an open-label, multicenter, randomized study evaluated the quality of life prospectively in Crohn’s patients who treated with Ustekinumab.

Ahsen Ustaoglu talks to Dr Martjin Jong (the Netherlands) on their recent paper developing an image-based deep learning system for primary detection of early Barrett's neoplasia

Dr. H. Tarik Kani talks to Dr Gabriele Dragoni (Italy) about his recent paper about the comparison of two strategies for the management of postoperative recurrence in Crohn’s disease which was a multicenter study evaluated the two strategies which are using in postoperative follow-up.

Ahsen Ustaoglu talks to Dr Nik Dekkers and Dr Jurjen Boonstra (the Netherlands) on their recent study investigating suitable imaging biomarker targets to differentiate high-grade dysplasia (HGD) and T1 colorectal cancer (T1CRC) from low-grade dysplasia (LGD) in colorectal polyps.

H. Tarik Kani talks to Dr Samuel Raimundo Fernandes (Portugal) about his recent paper about impact of transmural remission on clinical outcomes in Crohn's disease which was a multicenter study evaluated the clinical outcomes up to 5 years.

Ahsen Ustaoglu talks to Dr Nathaniel Cohen (Israel) about his recent paper on treat to target and sequencing therapies in Crohn’s disease, part of the Special issue: Changing Paradigms in Management of Inflammatory Bowel Disease.

Iago Rodríguez-Lago talks to Dr Erchinger (Norway) about his recent paper about pancreatic enzyme treatment, where he and all co-authors have evaluated the adherence to guidelines in a European cross‐sectional observational study.